Loading...

Parya Saberi, PharmD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Phone415-502-1000 ext. 66357
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.A.S. in Clinical Research2011 Graduate Division (Advance Training in Clinical Research)
    University of California, San Francisco Residency

    Collapse Overview 
    Collapse Overview
    Parya Saberi, PharmD, MAS is an Assistant Professor at the Center for AIDS Prevention Studies (CAPS) in the Department of Medicine at the University of California, San Francisco. Dr. Saberi is funded by the National Institute of Mental Health (NIMH) through a K23 Award, the California HIV Research Program (CHRP) for Health Disparities, the R21 mechanism from NIMH, and the UCSF Center for AIDS Research (CFAR) supplement. Her research includes assessing technology-based strategies such as mobile applications, video-conferencing tools, and text messaging to improve ART adherence and engagement in HIV care among youth living with HIV. She is also examining novel adherence assessment methods and an HIV pre-exposure prophylaxis (PrEP) tool for healthcare providers who are prescribing PrEP.


    Collapse Research 
    Collapse Research Activities and Funding
    Improving the HIV PrEP Cascade using an Intervention for Healthcare Providers
    NIH/NINR R01NR017573Sep 20, 2017 - Jun 30, 2021
    Role: Principal Investigator
    A Mobile Health Application for Engagement in Care among Youth Living with HIV
    NIH/NIMH R34MH114604Aug 15, 2017 - Jun 30, 2020
    Role: Principal Investigator
    Rx Pix: A Novel Way to Assess Antiretroviral Adherence with Pharmacy Refill Dates
    NIH/NIMH R21MH108414Feb 19, 2016 - Dec 31, 2017
    Role: Principal Investigator
    Technology-based adaptive treatment strategies for antiretroviral adherence
    NIH/NIMH K23MH097649Jun 15, 2012 - Apr 30, 2017
    Role: Principal Investigator
    Quality of Sleep in HIV-Infection: associations with treatment and adherence
    NIH/NIMH F32MH086323Jul 1, 2009 - Jun 30, 2012
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. Comparison of Measures of Adherence to HIV Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States. Clin Infect Dis. 2017 Aug 24. PMID: 29020194.
      View in: PubMed
    2. Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M. Strong Correlation between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. J Acquir Immune Defic Syndr. 2017 Jun 26. PMID: 28657913.
      View in: PubMed
    3. Sauceda JA, Neilands TB, Johnson MO, Saberi P. An update on the Barriers to Adherence and a Definition of Self-Report Non-adherence Given Advancements in Antiretroviral Therapy (ART). AIDS Behav. 2017 Mar 28. PMID: 28352983.
      View in: PubMed
    4. Sauceda JA, Johnson MO, Saberi P, et al. Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era? AIDS Behav. 2016 Nov; 20(11):2624-2628. PMID: 26767532.
      View in: PubMed
    5. van den Berg JJ, Neilands TB, Johnson MO, Chen B, Saberi P. Using Path Analysis to Evaluate the Healthcare Empowerment Model Among Persons Living with HIV for Antiretroviral Therapy Adherence. AIDS Patient Care STDS. 2016 Nov; 30(11):497-505. PMID: 27849372.
      View in: PubMed
    6. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. AIDS Patient Care STDS. 2016 Jun; 30(6):254-60. PMID: 27214751; PMCID: PMC4913493 [Available on 06/01/17].
    7. Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Trials. 2016 Feb 06; 17:68. PMID: 26852237; PMCID: PMC4744624.
    8. Gilvydis JM, Steward WT, Saberi P, Tumbo J, Sumitani J, Barnhart S, Lippman SA. Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS Care. 2015; 27(10):1275-8. PMID: 26278130; PMCID: PMC4780844.
    9. Saberi P, Johnson MO. Correlation of Internet Use for Health Care Engagement Purposes and HIV Clinical Outcomes Among HIV-Positive Individuals Using Online Social Media. J Health Commun. 2015; 20(9):1026-32. PMID: 26120890; PMCID: PMC4699567.
    10. Saberi P, Catz SL, Leyden WA, Stewart C, Ralston JD, Horberg MA, Grothaus L, Silverberg MJ. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85. PMID: 25572829; PMCID: PMC4497945.
    11. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS. 2015 Mar; 29(3):111-6. PMID: 25615029; PMCID: PMC4352694.
    12. Saberi P, Mayer K, Vittinghoff E, Naar-King S. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS Behav. 2015 Jan; 19(1):93-103. PMID: 24879628; PMCID: PMC4250439.
    13. Saberi P, Johnson MO. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care. 2015; 27(5):660-4. PMID: 25471139; PMCID: PMC4336586.
    14. Saberi P, Neilands TB, Johnson MO. Association between dog guardianship and HIV clinical outcomes. J Int Assoc Provid AIDS Care. 2014 Jul-Aug; 13(4):300-4. PMID: 25436253; PMCID: PMC3995900.
    15. Saberi P, Neilands TB, Johnson MO. Association between dog guardianship and HIV clinical outcomes. J Int Assoc Provid AIDS Care. 2014 Jul-Aug; 13(4):300-4. PMID: 25513022.
      View in: PubMed
    16. Yuan P, Bare MG, Johnson MO, Saberi P. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014 May 01; 16(5):e117. PMID: 24784982; PMCID: PMC4026571.
    17. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. PMID: 24646419; PMCID: PMC4054817.
    18. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. PMID: 24467531; PMCID: PMC4112174.
    19. Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32. PMID: 23991691; PMCID: PMC3760070.
    20. Saberi P, Comfort M, Sheon N, Johnson MO. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence. 2013; 7:499-507. PMID: 23807839; PMCID: PMC3687846.
    21. Saberi P, Phengrasamy T, Nguyen DP. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013 Oct; 14(9):519-29. PMID: 23590676; PMCID: PMC3758391.
    22. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061. PMID: 23166819; PMCID: PMC3498189.
    23. Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012 Dec; 34(6):803-6. PMID: 23073703; PMCID: PMC3501608.
    24. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012 Oct; 89(5):794-801. PMID: 22547327; PMCID: PMC3462822.
    25. Saberi P, Comfort M, Johnson MO. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. J Acquir Immune Defic Syndr. 2012 Sep 01; 61(1):e3-6. PMID: 22918127; PMCID: PMC3427530.
    26. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. PMID: 22654510; PMCID: PMC3363300.
    27. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. PMID: 22536064; PMCID: PMC3333818.
    28. Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011; 6(11):e27533. PMID: 22140446; PMCID: PMC3227571.
    29. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. Medication adherence: tailoring the analysis to the data. AIDS Behav. 2011 Oct; 15(7):1447-53. PMID: 21833689; PMCID: PMC3216469.
    30. Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011 Sep; 25(9):517-24. PMID: 21770763; PMCID: PMC3157301.
    31. Bruno CB, Schapiro JM, Saberi P. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug; 10(4):219-22. PMID: 21518854; PMCID: PMC3222949.
    32. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61. PMID: 21361735; PMCID: PMC3091502.
    33. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010 Oct; 22(10):1189-94. PMID: 20640958.
      View in: PubMed
    34. Saberi P, Caswell N, Amodio-Groton M, Alpert P. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 Jul; 20(6):741-5. PMID: 18576177.
      View in: PubMed
    35. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6. PMID: 18413688.
      View in: PubMed
    Parya's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP